Douglas E. Faries

9.3k citations

154 papers · 7.0k indexed · 2 hit papers · h-index 42

Psychiatry and Mental health top 0.1%
- Schizophrenia research and treatment 39
- Attention Deficit Hyperactivity Disorder 27
- Bipolar Disorder and Treatment 19
Statistics and Probability top 0.5%
- Advanced Causal Inference Techniques 26
- Statistical Methods in Clinical Trials 20
- Statistical Methods and Inference 14
Clinical Psychology top 1%
Biological Psychiatry top 2%
Family Practice top 2%
Economics and Econometrics
- Health Systems, Economic Evaluations, Quality of Life 43
Pharmacology
- Treatment of Major Depression 24

Co-authors: Haya Ascher‐Svanum Baojin Zhu John H. Heiligenstein Thomas Spencer Joseph A. Johnston Tessa Kennedy‐Martin Sarah L. Hulin-Curtis Susan Robinson
Cited by: Psychiatry and Mental health Statistics and Probability Clinical Psychology
Partner nations: United States United Kingdom Canada

In The Last Decade

Douglas E. Faries

146 papers receiving 6.7k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2015 A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results
2001 Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study

Peers

Countries citing papers authored by Douglas E. Faries

Since Specialization

Citations

This map shows the geographic impact of Douglas E. Faries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas E. Faries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas E. Faries more than expected).

Fields of papers citing papers by Douglas E. Faries

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas E. Faries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas E. Faries. The network helps show where Douglas E. Faries may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Douglas E. Faries, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Douglas E. Faries Line = papers co-authored together Douglas E. Faries links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Double machine learning methods for estimating average treatment effects: a comparative study Xiaoqing Tan,Shu Yang,Wenyu Ye,Douglas E. Faries,Ilya Lipkovich,Zbigniew Kadziola	2025	0
2	Real Effect or Bias? Good Practices for Evaluating the Robustness of Evidence From Comparative Observational Studies Through Quantitative Sensitivity Analysis for Unmeasured Confounding Douglas E. Faries,Chenyin Gao,Xiang Zhang,Chad Hazlett,James D. Stamey,Shu Yang,Peng Ding,Mingyang Shan,Kristin M. Sheffield,Nancy A Dreyer	2024	0
3	Improving randomized controlled trial analysis via data-adaptive borrowing Chenyin Gao,Shu Yang,Mingyang Shan,Wenyu Ye,Ilya Lipkovich,Douglas E. Faries	2024	1
4	Propensity score matching for estimating a marginal hazard ratio Tongrong Wang,Honghe Zhao,Shu Yang,Shuhan Tang,Zhanglin Lin Cui,Li Li,Douglas E. Faries	2024	0
5	Reweighting estimators to extend the external validity of clinical trials: methodological considerations Eloise Kaizar,Chen‐Yen Lin,Douglas E. Faries,Joseph A. Johnston	2023	3
6	A Simulation-Based Evaluation of Statistical Methods for Hybrid Real-World Control Arms in Clinical Trials Mingyang Shan,Douglas E. Faries,Andy Dang,Xiang Zhang,Zhanglin Lin Cui,Kristin M. Sheffield	2022	4
7	Comparative Effectiveness of Dexamethasone in Hospitalized COVID-19 Patients in the United States Casey Choong,Mark Belger,Alisa E. Koch,Kristin J. Meyers,Vincent C. Marconi,Hamed Abedtash,Douglas E. Faries,Venkatesh Krishnan	2022	0
8	A Bayesian approach to correct for unmeasured or semi-unmeasured confounding in survival data using multiple validation data sets Wencong Chen,Xiang Zhang,Douglas E. Faries,Wei Shen,John W. Seaman,James D. Stamey	2022	0
9	Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study Richard B. Lipton,Robert A. Nicholson,Michael L. Reed,Andre B. Araujo,Dena H. Jaffe,Douglas E. Faries,Dawn C. Buse,Robert E. Shapiro,Sait Ashina,M. Janelle Cambron‐Mellott,John Rowland,Eric Pearlman	2022	76
10	Practical recommendations on double score matching for estimating causal effects Yunshu Zhang,Shu Yang,Wenyu Ye,Douglas E. Faries,Ilya Lipkovich,Zbigniew Kadziola	2021	8
11	Digital Tracking of Rheumatoid Arthritis Longitudinally (DIGITAL) Using Biosensor and Patient-Reported Outcome Data: Protocol for a Real-World Study W. Benjamin Nowell,Jeffrey R. Curtis,Sandra Nolot,David Curtis,Shilpa Venkatachalam,Justin K. Owensby,Jiat Ling Poon,Amy B Calvin,Carol L. Kannowski,Douglas E. Faries,Kelly Gavigan,Virginia S. Haynes	2019	15
12	Medical costs of Alzheimer's disease misdiagnosis among US Medicare beneficiaries Craig Hunter,Noam Y. Kirson,Urvi Desai,Alice Kate G. Cummings,Douglas E. Faries,Howard G. Birnbaum	2015	48
13	Longitudinal analysis of healthcare costs: a case study of patients with major depressive disorder treated with duloxetine Zhanglin Lin Cui,Douglas E. Faries,Wei Shen,Stephen L. Able,Diego Novick	2013	1
14	Longitudinal Observation of Treatment Patterns and Outcomes for Patients with Fibromyalgia: 12-Month Findings from the REFLECTIONS Study R.L. Robinson,Kurt Kroenke,David A. Williams,Philip J. Mease,Yi Chen,Douglas E. Faries,Xiaomei Peng,Danette Hann,Madelaine M. Wohlreich,Bill McCarberg	2013	35
15	Local control for identifying subgroups of interest in observational research: persistence of treatment for major depressive disorder Douglas E. Faries,Yi Chen,Ilya Lipkovich,Anthony J. Zagar,Xianchen Liu,Robert L. Obenchain	2013	13
16	Dosing Patterns for Duloxetine and Predictors of High-Dose Prescriptions in Patients With Major Depressive Disorder: Analysis from a United States Third-Party Payer Perspective Xianchen Liu,Zhanglin Lin Cui,Liyuan Niu,Douglas E. Faries,Tamara Ball,Bryan M. Johnstone	2011	3
17	A Provisional Screening Instrument for Four Common Mental Disorders in Adult Primary Care Patients John P. Houston,Kurt Kroenke,Douglas E. Faries,Caroline Carney Doebbeling,Lenard A. Adler,Jonna Ahl,Ralph Swindle,Paula T. Trzepacz	2011	23
18	The Life Participation Scale for Attention-Deficit/Hyperactivity Disorder–Child Version: Psychometric Properties of an Adaptive Change Instrument Keith E. Saylor,Curt Buermeyer,Virginia K. Sutton,Douglas E. Faries,Sajjad Khan,Kory Schuh	2007	16
19	Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia Haya Ascher‐Svanum,Baojin Zhu,Douglas E. Faries,Ron Landbloom,Marvin S. Swartz,Jeff W. Swanson	2006	96
20	The Double-Blind Variable Placebo Lead-in Period: Results From Two Antidepressant Clinical Trials Douglas E. Faries,John H. Heiligenstein,G.D. Tollefson,William Z. Potter	2001	60

About Douglas E. Faries

Douglas E. Faries is a scholar working on Psychiatry and Mental health, Statistics and Probability and Economics and Econometrics, having authored 154 papers that have together received 7.0k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (43 papers), Schizophrenia research and treatment (39 papers), Attention Deficit Hyperactivity Disorder (27 papers), Advanced Causal Inference Techniques (26 papers), Treatment of Major Depression (24 papers), Statistical Methods in Clinical Trials (20 papers), Bipolar Disorder and Treatment (19 papers) and Statistical Methods and Inference (14 papers). The work is most often cited by research in Psychiatry and Mental health (4.4k citations), Statistics and Probability (656 citations) and Clinical Psychology (1.4k citations). Douglas E. Faries has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Haya Ascher‐Svanum, Baojin Zhu, John H. Heiligenstein, Thomas Spencer, Joseph A. Johnston, Tessa Kennedy‐Martin, Sarah L. Hulin-Curtis, Susan Robinson, Joachim Wernicke and Douglas K. Kelsey.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact